Skip to main content
OpenTrials

Clinical trial condition

Bile Duct Diseases

Explore clinical trials studying Bile Duct Diseases. Study availability and eligibility vary by location and protocol.

667 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Bile Duct Diseases trial results

Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

NCT04003636

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 0008) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0014) Los Angeles, California, United States
  • University of California - San Francisco ( Site 0030) San Francisco, California, United States
View all 185 locations
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • OM Research Lancaster, California, United States
  • University of California Davis Health Sacramento, California, United States
  • Peak Gastroenterology Associates Colorado Springs, Colorado, United States
View all 19 locations
View Trial Details
Completed

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449

Conditions
Bile Duct Diseases, Biliary Cirrhosis, Primary, Biliary Tract Diseases, +9 more
Locations
  • Institute for Liver Health Chandler, Arizona, United States
  • Banner University Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 39 locations
View Trial Details
Completed

A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)

NCT05543174

Conditions
Abnormalities, Multiple, Alagille Syndrome, Alagille Syndrome (ALGS), +12 more
Locations
  • University of Tsukuba Hospital Tsukuba, Ibaraki, Japan
  • Yokohamashi Tobu Hospital Yokohama, Kanagawa, Japan
  • Miyagi Children's Hospital Sendai, Miyagi, Japan
  • Kindai University Nara Hospital Ikoma, Nara, Japan
View Trial Details
Completed

Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)

NCT04480840

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • California Liver Research Institute Pasadena, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 60 locations
View Trial Details

Related conditions